42 results
8-K
EX-10.6
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
) promptly payable in United States dollars free of any tax, deduction or offset (with respect to monetary awards). Subject to the Appeal Right, any … , or accountings presented or pleaded in the Arbitration, and (d) be promptly payable in United States dollars free of any tax, deduction or offset
8-K
EX-10.2
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
to the arbitrator, and (c) promptly payable in United States dollars free of any tax, deduction or offset (with respect to monetary awards). Subject … , deduction or offset (with respect to monetary awards). Any costs or fees, including without limitation attorneys’ fees, incurred in connection
8-K
EX-10.1
phzj 69dc8v498g9
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.2
mrt09fo
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
s19mwesusvd91zz
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
i7qpd0sx
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.4
kmlu9d4s
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-99.2
ye46j1e4 6gzr0wkttr4
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-99.1
x29nko072
5 Oct 23
Index to Financial Statements
5:12pm
424B3
tst0 3j9u7
14 Aug 23
Prospectus supplement
4:30pm